Back to search

Article

High-Throughput Screening and Initial SAR Studies Identify a Novel Sub-micromolar Potent Human cGAS Inhibitor

2025-08-22

Abstract excerpt

Cyclic GMP-AMP synthase (cGAS) has emerged as a promising therapeutic target of several human diseases, including Alzheimer’s disease (AD) and other neurodegenerative disorders. As a cytosolic DNA sensor, cGAS generates an innate immune response to promote neuroinflammation by producing an endogenous agonist of the stimulator of interferon genes (STING), 2’3’-cyclic GMP-AMP (cGAMP), which activates the cGAS–STING...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
46863c39-13ca-5cf2-bb2d-cb26fb8d4cd9
DOI
10.1101/2025.08.18.670979
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
High-Throughput Screening and Initial SAR Studies Identify a Novel Sub-micromolar Potent Human cGAS InhibitorDOI 10.1101/2025.08.18.670979
Select a neighboring publication to make it the new centre.